(Q38962473)

8 September 2017

title

Modular multiantigen T cell epitope-enriched DNA vaccine against human leishmaniasis (English)

1 reference

8 September 2017

author

Nina Sacerdoti-Sierra

8

object named as

Nina Sacerdoti-Sierra

0 references

author name string

Shantanabha Das

1

1 reference

8 September 2017

Anja Freier

2

1 reference

8 September 2017

Thouraya Boussoffara

3

1 reference

8 September 2017

Sushmita Das

4

1 reference

8 September 2017

Detlef Oswald

5

1 reference

8 September 2017

Florian O Losch

6

1 reference

8 September 2017

Melanie Selka

7

1 reference

8 September 2017

Nina Sacerdoti-Sierra

8

1 reference

8 September 2017

Gabriele Schönian

9

1 reference

8 September 2017

Karl-Heinz Wiesmüller

10

1 reference

8 September 2017

Karin Seifert

11

1 reference

8 September 2017

Matthias Schroff

12

1 reference

8 September 2017

Christiane Juhls

13

1 reference

8 September 2017

Charles L Jaffe

14

1 reference

8 September 2017

Syamal Roy

15

1 reference

8 September 2017

Pradeep Das

16

1 reference

8 September 2017

Hechmi Louzir

17

1 reference

8 September 2017

Simon L Croft

18

1 reference

8 September 2017

Farrokh Modabber

19

1 reference

8 September 2017

Peter Walden

20

1 reference

8 September 2017

language of work or name

English

0 references

publication date

1 April 2014

1 reference

Science Translational Medicine

8 September 2017

published in

1 reference

8 September 2017

volume

6

1 reference

8 September 2017

issue

234

1 reference

8 September 2017

page(s)

234ra56

1 reference

Leishmaniasis worldwide and global estimates of its incidence

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008222

Leishmaniasis: complexity at the host-pathogen interface.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008222

Leishmaniasis chemotherapy--challenges and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008222

A review of preventative methods against human leishmaniasis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008222

Vaccines for canine leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008222

Balancing immunity and pathology in visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008222

Development of Vaccines against Visceral Leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008222

Incidence of symptomatic and asymptomatic Leishmania donovani infections in high-endemic foci in India and Nepal: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008222

Vaccines for the leishmaniases: proposals for a research agenda

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008222

Visceral leishmaniasis: immunology and prospects for a vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008222

The development and clinical evaluation of second-generation leishmaniasis vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008222

Therapeutic vaccination with recombinant adenovirus reduces splenic parasite burden in experimental visceral leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008222

Pathways of antigen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008222

Principles of vaccine design-Lessons from nature

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008222

DNA vaccines: ready for prime time?

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008222

Biosafety of DNA vaccines: New generation of DNA vectors and current knowledge on the fate of plasmids after injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008222

DNA vaccination with linear minimalistic (MIDGE) vectors confers protection against Leishmania major infection in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008222

HLA class I-restricted T cell epitopes of the kinetoplastid membrane protein-11 presented by Leishmania donovani-infected human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008222

KMP-11 DNA immunization significantly protects against L. donovani infection but requires exogenous IL-12 as an adjuvant for comparable protection against L. major.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008222

Prime-boost vaccination using cysteine proteinases type I and II of Leishmania infantum confers protective immunity in murine visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008222

Approaches for the identification of potential excreted/secreted proteins of Leishmania major parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008222

First generation leishmaniasis vaccines: a review of field efficacy trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008222

Clinical applications of DNA vaccines: current progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008222

Leishmanin skin test lymphoproliferative responses and cytokine production after symptomatic or asymptomatic Leishmania major infection in Tunisia

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008222

A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008222

10.1126/SCITRANSLMED.3008222

21 January 2018

Identifiers

DOI

1 reference

8 September 2017

1 reference